Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Philips has become aware that while performing a clinical spect/cy study on a brightview xct spect/ct system the ct portion of the scan may be interrupted (stopping the ct exposure at the time of interruption) and may not complete sucessfully. an incomplete study may result in the operator having to retry the interrupted segment acquisition to complete the patient exam.